CTKB
Cytek Biosciences, Inc.
Key Financials
Operating Income
$-40384000
↓ 96.8%
Net Income
$-66539000
↓ 1005.3%
Gross Profit
$104.5M
↓ 6.0%
EPS (Diluted)
$-0.09
↓ 550.0%
Total Assets
$461.5M
↓ 7.6%
Total Liabilities
$119.8M
↑ 15.5%
Shareholders' Equity
$341.7M
↓ 13.6%
Cash & Equivalents
$90.9M
↓ 8.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G | 8/4/2026 | View on SEC |
| 8-K | 7/15/2026 | View on SEC |
| SCHEDULE 13G/A | 7/8/2026 | View on SEC |
| 3 | 6/30/2026 | View on SEC |
| 8-K | 6/25/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTKB |
| Company Name | Cytek Biosciences, Inc. |
| CIK | 1831915 |
| Sector | Laboratory Analytical Instruments |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (877) 922-9835 |